#London #United Kingdom #Sage #AI Research #Causaly

Causaly Partners with Sage to Transform Drug Discovery

In a groundbreaking collaboration, Causaly, renowned for its advanced Agentic AI platform tailored for life sciences, has joined forces with Sage, a prominent global academic publisher. This strategic partnership allows Causaly's AI agents to access and process the full text of over 400 Sage and Mary Ann Leibert journals, significantly enhancing the capabilities of researchers in the field.

The importance of this collaboration can’t be understated. Marco Costa, COO of Causaly, emphasizes that this union is a response to a critical demand from their users. He states, "Partnering with Sage gives our customers the capability to utilize a single platform that integrates evidence with scientifically governed reasoning." This means that for scientists working on drug discovery and other research endeavors, the platform will now facilitate quicker and more reliable access to critical insights drawn from existing license agreements they hold.

Causaly’s AI agents are designed to analyze full-text articles comprehensively, incorporating methods, results tables, and auxiliary data—elements that are vital for discerning the relevance and rigor of scientific papers. The integration of Sage’s full-text articles allows Causaly to provide a richer, more context-driven view of the research content, especially pertinent for validating drug discovery hypotheses.

The integration enables all Causaly customers to access Sage full-text articles as an add-on feature. Customers subscribed to Sage journals can seamlessly link from Causaly’s summary analysis to the full articles on Sage’s platform. Those who do not have a Sage subscription will still benefit, as Causaly provides a concise snapshot of the articles along with an in-platform option to purchase full access on Sage.

This innovative approach addresses a well-documented inefficiency faced by researchers when acquiring scientific literature. Traditionally, researchers often find themselves purchasing numerous papers only to discover that only a handful are pertinent to their inquiries. With this new integration, Causaly mitigates unnecessary spending by allowing users to judge the value of an article based on AI-powered analysis before they commit to an access purchase. This leads to reduced costs and accelerates the pace of research and insights.

Bob Howard, Executive Vice President of Global Journals at Sage, adds, "Sage has always been devoted to furnishing researchers with impactful knowledge in practical formats. Integrating Sage content within Causaly’s AI platform allows us to broaden our influence and connection to those engaged in key research tasks. This partnership embodies our commitment to enhancing access and intelligence for researchers—placing them both at their fingertips."

The collaboration signifies a pivotal moment in research workflows for scientific inquiries, particularly in drug discovery. By merging Causaly’s sophisticated AI technology with Sage's extensive academic resources, both parties intend to streamline the research process, empowering scientists to derive insights faster and more confidently than ever before.

For more detailed information, potential customers, and interested parties can visit Causaly's Partner Page.

About Causaly

Causaly is noted as the agentic AI platform expressly crafted for life sciences research and development. Utilizing a high-precision biomedical knowledge graph in conjunction with the global body of scientific literature, Causaly empowers specialized AI agents designed to automate scientific workflows, thereby reducing the time and complexity associated with drug discovery and development processes.

About Sage

Founded in 1965 by Sara Miller McCune, Sage has evolved into a leading global academic publisher committed to connecting researchers with essential educational tools. The company is guided by a board of trustees to maintain its independence and mission, expanding its reach through innovative technologies that enhance discovery, access, and engagement in educational contexts.

Through this partnership, both Causaly and Sage stand to significantly elevate the caliber and efficiency of research globally, driving forward scientific innovation dependent on robust, evidence-based practices.